NCT03096353View on ClinicalTrials.gov

Sensory and Opioid Mechanisms of Affective Touch

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

October 31, 2018

Study Completion Date

October 31, 2018

Conditions
PainTouch
Interventions
OTHER

Placebo

saline

DRUG

Naloxone

We will be using naloxone at normal clinical doses as the study drug. Naloxone is an opiate antagonist and has been used since the 1960 s to reverse the effects of opiate overdoses.

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Center for Complementary and Integrative Health (NCCIH)

NIH

NCT03096353 - Sensory and Opioid Mechanisms of Affective Touch | Biotech Hunter | Biotech Hunter